nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ2—refractive error	0.00631	0.00631	CbGpPWpGaD
Vemurafenib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—refractive error	0.00627	0.00627	CbGpPWpGaD
Vemurafenib—BRAF—Focal Adhesion—LAMA2—refractive error	0.00608	0.00608	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—RASGRF1—refractive error	0.0059	0.0059	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—GJD2—refractive error	0.00553	0.00553	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—GRIA4—refractive error	0.00548	0.00548	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—PML—refractive error	0.00539	0.00539	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—RASGRF1—refractive error	0.00532	0.00532	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—KCNJ2—refractive error	0.00526	0.00526	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways in Glioblastoma—PDGFRA—refractive error	0.00523	0.00523	CbGpPWpGaD
Vemurafenib—BRAF—Focal Adhesion—COL2A1—refractive error	0.00521	0.00521	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—GRIA4—refractive error	0.00495	0.00495	CbGpPWpGaD
Vemurafenib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—refractive error	0.00484	0.00484	CbGpPWpGaD
Vemurafenib—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—refractive error	0.00477	0.00477	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—BMP2—refractive error	0.00476	0.00476	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—KCNJ2—refractive error	0.00475	0.00475	CbGpPWpGaD
Vemurafenib—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—refractive error	0.0047	0.0047	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—ROBO3—refractive error	0.00465	0.00465	CbGpPWpGaD
Vemurafenib—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—refractive error	0.00464	0.00464	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—COL9A1—refractive error	0.00447	0.00447	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—EBP—refractive error	0.00435	0.00435	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—LAMA2—refractive error	0.0042	0.0042	CbGpPWpGaD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—PML—refractive error	0.00416	0.00416	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—RASGRF1—refractive error	0.00408	0.00408	CbGpPWpGaD
Vemurafenib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—refractive error	0.00398	0.00398	CbGpPWpGaD
Vemurafenib—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—refractive error	0.00393	0.00393	CbGpPWpGaD
Vemurafenib—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—refractive error	0.00381	0.00381	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—GRIA4—refractive error	0.00379	0.00379	CbGpPWpGaD
Vemurafenib—RAF1—Signaling of Hepatocyte Growth Factor Receptor—PTEN—refractive error	0.00376	0.00376	CbGpPWpGaD
Vemurafenib—RAF1—BDNF signaling pathway—BMP2—refractive error	0.0037	0.0037	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—KCNJ2—refractive error	0.00364	0.00364	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways in Glioblastoma—PDGFRA—refractive error	0.00362	0.00362	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—COL2A1—refractive error	0.00361	0.00361	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—ROBO3—refractive error	0.00332	0.00332	CbGpPWpGaD
Vemurafenib—BRAF—Regulation of Actin Cytoskeleton—PDGFRA—refractive error	0.00325	0.00325	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—refractive error	0.00323	0.00323	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—SALL4—refractive error	0.00317	0.00317	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—CACNA1D—refractive error	0.00311	0.00311	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—PML—refractive error	0.00309	0.00309	CbGpPWpGaD
Vemurafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—refractive error	0.00307	0.00307	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR—PDGFRA—refractive error	0.00304	0.00304	CbGpPWpGaD
Vemurafenib—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—refractive error	0.00303	0.00303	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.00294	0.00294	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.00294	0.00294	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—PDGFRA—refractive error	0.00283	0.00283	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—COL9A1—refractive error	0.00282	0.00282	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—GREM2—refractive error	0.00278	0.00278	CbGpPWpGaD
Vemurafenib—RAF1—Signaling events mediated by Stem cell factor receptor (c-Kit)—PTEN—refractive error	0.00272	0.00272	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways in Glioblastoma—PTEN—refractive error	0.00269	0.00269	CbGpPWpGaD
Vemurafenib—BRAF—Focal Adhesion—PDGFRA—refractive error	0.00267	0.00267	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—CER1—refractive error	0.00266	0.00266	CbGpPWpGaD
Vemurafenib—BRAF—Disease—DSE—refractive error	0.00256	0.00256	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—BUB1B—refractive error	0.00254	0.00254	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—PDGFRA—refractive error	0.0025	0.0025	CbGpPWpGaD
Vemurafenib—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—refractive error	0.00249	0.00249	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—OR2M7—refractive error	0.00247	0.00247	CbGpPWpGaD
Vemurafenib—BRAF—Disease—RDH5—refractive error	0.0024	0.0024	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CHN1—refractive error	0.00236	0.00236	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—EBP—refractive error	0.00236	0.00236	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—PDGFRA—refractive error	0.00235	0.00235	CbGpPWpGaD
Vemurafenib—BRAF—Disease—PCCA—refractive error	0.00228	0.00228	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—PML—refractive error	0.00228	0.00228	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IFITM2—refractive error	0.00225	0.00225	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—RNF111—refractive error	0.00225	0.00225	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of Actin Cytoskeleton—PDGFRA—refractive error	0.00225	0.00225	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—PDGFRA—refractive error	0.00225	0.00225	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—CACNA1D—refractive error	0.00222	0.00222	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—PDGFRA—refractive error	0.00221	0.00221	CbGpPWpGaD
Vemurafenib—BRAF—Senescence and Autophagy in Cancer—PTEN—refractive error	0.0022	0.0022	CbGpPWpGaD
Vemurafenib—RAF1—BCR signaling pathway—PTEN—refractive error	0.00218	0.00218	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—PDGFRA—refractive error	0.00211	0.00211	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—OR2M7—refractive error	0.00211	0.00211	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—PDGFRA—refractive error	0.0021	0.0021	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—VIPR2—refractive error	0.0021	0.0021	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—PDGFRA—refractive error	0.00209	0.00209	CbGpPWpGaD
Vemurafenib—BRAF—Disease—IPO5—refractive error	0.00209	0.00209	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—PDGFRA—refractive error	0.00208	0.00208	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—CYP26A1—refractive error	0.00202	0.00202	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—COL9A1—refractive error	0.00201	0.00201	CbGpPWpGaD
Vemurafenib—CYP2D6—Metapathway biotransformation—CYP26A1—refractive error	0.002	0.002	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—PDGFRA—refractive error	0.00196	0.00196	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—PDGFRA—refractive error	0.00196	0.00196	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—PDGFRA—refractive error	0.00196	0.00196	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—PDGFRA—refractive error	0.00194	0.00194	CbGpPWpGaD
Vemurafenib—BRAF—Disease—WNT10A—refractive error	0.00194	0.00194	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—EBP—refractive error	0.00194	0.00194	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—PDGFRA—refractive error	0.00193	0.00193	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—GREM2—refractive error	0.00192	0.00192	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—PDGFRA—refractive error	0.00192	0.00192	CbGpPWpGaD
Vemurafenib—BRAF—PDGFR-beta signaling pathway—PTEN—refractive error	0.00192	0.00192	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CTSC—refractive error	0.00191	0.00191	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—PDGFRA—refractive error	0.00191	0.00191	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways in Glioblastoma—PTEN—refractive error	0.00186	0.00186	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—PDGFRA—refractive error	0.00185	0.00185	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.00184	0.00184	CbGpPWpGaD
Vemurafenib—BRAF—Disease—RNF111—refractive error	0.00182	0.00182	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—VIPR2—refractive error	0.00179	0.00179	CbGpPWpGaD
Vemurafenib—RAF1—Disease—DSE—refractive error	0.00177	0.00177	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—DSE—refractive error	0.00175	0.00175	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—PDGFRA—refractive error	0.00173	0.00173	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—CYP26A1—refractive error	0.00171	0.00171	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—EBP—refractive error	0.00171	0.00171	CbGpPWpGaD
Vemurafenib—CYP1A2—Metapathway biotransformation—CYP26A1—refractive error	0.00169	0.00169	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—RDH5—refractive error	0.00168	0.00168	CbGpPWpGaD
Vemurafenib—RAF1—Disease—RDH5—refractive error	0.00166	0.00166	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—EBP—refractive error	0.00165	0.00165	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—RDH5—refractive error	0.00165	0.00165	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—PTEN—refractive error	0.00165	0.00165	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CHN1—refractive error	0.00164	0.00164	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—AXL—refractive error	0.0016	0.0016	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.0016	0.0016	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.0016	0.0016	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—WNT10A—refractive error	0.00159	0.00159	CbGpPWpGaD
Vemurafenib—BRAF—Disease—LUM—refractive error	0.00158	0.00158	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PCCA—refractive error	0.00158	0.00158	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PCCA—refractive error	0.00156	0.00156	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR—PTEN—refractive error	0.00156	0.00156	CbGpPWpGaD
Vemurafenib—BRAF—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.00156	0.00156	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—TUBB3—refractive error	0.00155	0.00155	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—TUBB3—refractive error	0.00153	0.00153	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—PTEN—refractive error	0.00153	0.00153	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—DSE—refractive error	0.00147	0.00147	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—VANGL2—refractive error	0.00146	0.00146	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—OR2M7—refractive error	0.00146	0.00146	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—PTEN—refractive error	0.00145	0.00145	CbGpPWpGaD
Vemurafenib—RAF1—Disease—IPO5—refractive error	0.00144	0.00144	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—IPO5—refractive error	0.00143	0.00143	CbGpPWpGaD
Vemurafenib—BRAF—Focal Adhesion—PTEN—refractive error	0.00137	0.00137	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—RNF111—refractive error	0.00137	0.00137	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—WNT10A—refractive error	0.00136	0.00136	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—TUBB3—refractive error	0.00135	0.00135	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—PAX6—refractive error	0.00134	0.00134	CbGpPWpGaD
Vemurafenib—RAF1—Disease—WNT10A—refractive error	0.00134	0.00134	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—PDGFRA—refractive error	0.00133	0.00133	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—WNT10A—refractive error	0.00133	0.00133	CbGpPWpGaD
Vemurafenib—RAF1—PDGFR-beta signaling pathway—PTEN—refractive error	0.00133	0.00133	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—CYP26A1—refractive error	0.00132	0.00132	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PCCA—refractive error	0.00131	0.00131	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PLA2G16—refractive error	0.00131	0.00131	CbGpPWpGaD
Vemurafenib—CYP3A4—Metapathway biotransformation—CYP26A1—refractive error	0.0013	0.0013	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—DSE—refractive error	0.00129	0.00129	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.00129	0.00129	CbGpPWpGaD
Vemurafenib—BRAF—Disease—RPS27—refractive error	0.00128	0.00128	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—RNF111—refractive error	0.00128	0.00128	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CER1—refractive error	0.00128	0.00128	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TJP2—refractive error	0.00128	0.00128	CbGpPWpGaD
Vemurafenib—RAF1—Disease—RNF111—refractive error	0.00126	0.00126	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—RNF111—refractive error	0.00125	0.00125	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—VIPR2—refractive error	0.00124	0.00124	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—PTEN—refractive error	0.0012	0.0012	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—RDH5—refractive error	0.00117	0.00117	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CTSC—refractive error	0.00116	0.00116	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—PTEN—refractive error	0.00115	0.00115	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PLA2G16—refractive error	0.00115	0.00115	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PCCA—refractive error	0.00115	0.00115	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—PTEN—refractive error	0.00113	0.00113	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.00112	0.00112	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.00112	0.00112	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—AXL—refractive error	0.0011	0.0011	CbGpPWpGaD
Vemurafenib—RAF1—Disease—LUM—refractive error	0.00109	0.00109	CbGpPWpGaD
Vemurafenib—RAF1—Insulin Signaling—PTEN—refractive error	0.00109	0.00109	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—LUM—refractive error	0.00108	0.00108	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—PTEN—refractive error	0.00108	0.00108	CbGpPWpGaD
Vemurafenib—RAF1—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.00108	0.00108	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—PTEN—refractive error	0.00108	0.00108	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—PTEN—refractive error	0.00107	0.00107	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—PTEN—refractive error	0.00107	0.00107	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—EBP—refractive error	0.00105	0.00105	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—VANGL2—refractive error	0.00101	0.00101	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.001	0.001	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—PTEN—refractive error	0.001	0.001	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—PTEN—refractive error	0.001	0.001	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—PTEN—refractive error	0.000995	0.000995	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—PTEN—refractive error	0.000989	0.000989	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—PTEN—refractive error	0.000987	0.000987	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—PTEN—refractive error	0.000982	0.000982	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—COL9A1—refractive error	0.000967	0.000967	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—PTEN—refractive error	0.000949	0.000949	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.000945	0.000945	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—WNT10A—refractive error	0.000939	0.000939	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—LUM—refractive error	0.000908	0.000908	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.00089	0.00089	CbGpPWpGaD
Vemurafenib—RAF1—Disease—RPS27—refractive error	0.000884	0.000884	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—RNF111—refractive error	0.000883	0.000883	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TJP2—refractive error	0.000883	0.000883	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CER1—refractive error	0.000883	0.000883	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—RPS27—refractive error	0.000876	0.000876	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CACNA1D—refractive error	0.000874	0.000874	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—EBP—refractive error	0.000869	0.000869	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—TUBB3—refractive error	0.000832	0.000832	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—LUM—refractive error	0.000799	0.000799	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—DSE—refractive error	0.000798	0.000798	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CYP26A1—refractive error	0.000772	0.000772	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CACNA1D—refractive error	0.000769	0.000769	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—PDGFRA—refractive error	0.00076	0.00076	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—PML—refractive error	0.000744	0.000744	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—EBP—refractive error	0.000736	0.000736	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—PDGFRA—refractive error	0.00073	0.00073	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PLA2G16—refractive error	0.000711	0.000711	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PCCA—refractive error	0.000711	0.000711	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—PTEN—refractive error	0.000684	0.000684	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CYP26A1—refractive error	0.000679	0.000679	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—COL9A1—refractive error	0.000669	0.000669	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—BMP2—refractive error	0.000663	0.000663	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—DSE—refractive error	0.000659	0.000659	CbGpPWpGaD
Vemurafenib—BRAF—Disease—PDGFRA—refractive error	0.000591	0.000591	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PCCA—refractive error	0.000587	0.000587	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PLA2G16—refractive error	0.000587	0.000587	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—EBP—refractive error	0.000568	0.000568	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—DSE—refractive error	0.000558	0.000558	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PLA2G16—refractive error	0.000497	0.000497	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PCCA—refractive error	0.000497	0.000497	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—LUM—refractive error	0.000493	0.000493	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CACNA1D—refractive error	0.000474	0.000474	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—BMP2—refractive error	0.000459	0.000459	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—PDGFRA—refractive error	0.000443	0.000443	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—DSE—refractive error	0.000431	0.000431	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CYP26A1—refractive error	0.000419	0.000419	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—PDGFRA—refractive error	0.000414	0.000414	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PDGFRA—refractive error	0.000409	0.000409	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—LUM—refractive error	0.000407	0.000407	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PDGFRA—refractive error	0.000405	0.000405	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CACNA1D—refractive error	0.000392	0.000392	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000391	0.000391	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—PTEN—refractive error	0.00039	0.00039	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PLA2G16—refractive error	0.000384	0.000384	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PCCA—refractive error	0.000384	0.000384	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—PTEN—refractive error	0.000375	0.000375	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CYP26A1—refractive error	0.000346	0.000346	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—LUM—refractive error	0.000345	0.000345	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CACNA1D—refractive error	0.000332	0.000332	CbGpPWpGaD
Vemurafenib—BRAF—Disease—PTEN—refractive error	0.000303	0.000303	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CYP26A1—refractive error	0.000293	0.000293	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PDGFRA—refractive error	0.000286	0.000286	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—LUM—refractive error	0.000266	0.000266	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CACNA1D—refractive error	0.000256	0.000256	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—PTEN—refractive error	0.000227	0.000227	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CYP26A1—refractive error	0.000226	0.000226	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—PTEN—refractive error	0.000212	0.000212	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000212	0.000212	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PTEN—refractive error	0.00021	0.00021	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PTEN—refractive error	0.000208	0.000208	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PTEN—refractive error	0.000174	0.000174	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PTEN—refractive error	0.000153	0.000153	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000149	0.000149	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PTEN—refractive error	0.000147	0.000147	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PTEN—refractive error	9.46e-05	9.46e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PTEN—refractive error	7.81e-05	7.81e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PTEN—refractive error	6.62e-05	6.62e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PTEN—refractive error	5.11e-05	5.11e-05	CbGpPWpGaD
